AstraZeneca, Epidemiology R&D, Sweden; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Clin Cardiol. 2011 May;34(5):309-16. doi: 10.1002/clc.20869. Epub 2011 Mar 13.
The CHADS(2) score (C, congestive heart failure [CHF]; H, hypertension [HT]; A, age ≥75 y; D, diabetes mellitus; S(2) , prior stroke or transient ischemic attack) is used to assess the risk of ischemic stroke in patients with atrial fibrillation (AF). However, its role in patients without documented AF is not well explored.
The goal of the current study was to explore if the incidence of hospitalization with first-ever AF after stroke increased with increasing CHADS(2) score.
We identified 57636 patients with nonfatal stroke and no documented AF in the Swedish Stroke Register (Riks-Stroke) during 2001-2004 and followed them for a mean of 2.2 years through record linkage to the Inpatient and Cause of Death registers. Cox regression hazard models were used to estimate the relative risk (RR) of new AF following stroke and its association with different CHADS(2) scores.
Overall, 2769 patients were hospitalized with new AF (4.8%, 21.7 per 1000 person-years). The incidence increased from 9.6 per 1000 person-years in CHADS(2) score 0 to 42.7 in CHADS(2) score 6, conferring a RR of 4.2 (95% confidence interval [CI]: 2.5-6.8). For CHADS(2) scores 3-5, the RRs were approximately 3 (vs CHADS(2) score 0). Adjusted RRs were 1.9 (95% CI: 1.7-2.1) for CHF, 1.4 (95% CI: 1.3-1.5) for HT, 2.1 (95% CI: 2.0-2.3) for age ≥75 years, 0.9 (95% CI: 0.8-1.0) for diabetes, and 1.0 (95% CI: 0.91-1.07) for previous stroke. The risk of AF was higher in ischemic than in hemorrhagic stroke.
In this retrospective register study, the incidence of AF following stroke was strongly influenced by higher CHADS(2) scores where age ≥75 years, CHF, and HT were the contributing CHADS(2) components.
CHADS(2)评分(C,充血性心力衰竭[CHF];H,高血压[HT];A,年龄≥75 岁;D,糖尿病;S(2),既往卒中或短暂性脑缺血发作)用于评估心房颤动(AF)患者的缺血性卒中风险。然而,其在无记录 AF 患者中的作用尚未得到充分探索。
本研究旨在探讨 CHADS(2)评分升高是否与卒中后首次 AF 住院发生率增加相关。
我们在 2001-2004 年期间从瑞典卒中登记处(Riks-Stroke)中确定了 57636 例非致命性卒中且无记录 AF 的患者,并通过与住院和死因登记处的记录链接,平均随访 2.2 年。Cox 回归风险模型用于估计卒中后新发 AF 的相对风险(RR)及其与不同 CHADS(2)评分的关系。
总体而言,2769 例患者因新发 AF 住院(4.8%,21.7/1000 人年)。CHADS(2)评分 0 时的发生率为 9.6/1000 人年,而 CHADS(2)评分 6 时的发生率为 42.7/1000 人年,RR 为 4.2(95%置信区间[CI]:2.5-6.8)。CHADS(2)评分 3-5 时,RR 约为 3(与 CHADS(2)评分 0 相比)。校正后的 RR 为充血性心力衰竭(CHF)1.9(95%CI:1.7-2.1)、高血压(HT)1.4(95%CI:1.3-1.5)、年龄≥75 岁(2.1(95%CI:2.0-2.3)、糖尿病(0.9(95%CI:0.8-1.0)和既往卒中(1.0(95%CI:0.91-1.07)。缺血性卒中和出血性卒中相比,AF 风险更高。
在这项回顾性登记研究中,CHADS(2)评分较高与 AF 发生密切相关,其中年龄≥75 岁、CHF 和 HT 是 CHADS(2)评分的主要影响因素。